Computational investigation of Moringa oleifera phytochemicals targeting EGFR: molecular docking, molecular dynamics simulation and density functional theory studies

Abstract

Epidermal growth factor receptor (EGFR) is a prominent target for anticancer therapy due to its role in activating several cell signaling cascades. Clinically approved EGFR inhibitors are reported to show treatment resistance and toxicity, this study, therefore, investigates Moringa oleifera phytochemicals to find potent and safe anti-EGFR compounds. For that, phytochemicals were screened based on drug-likeness and molecular docking analysis followed by molecular dynamics simulation, density functional theory analysis and ADMET analysis to identify the effective inhibitors of EGFR tyrosine kinase (EGFR-TK) domain. Known EGFR-TK inhibitors (1-4 generations) were used as control. Among 146 phytochemicals, 136 compounds showed drug-likeness, of which Delta 7-Avenasterol was the most potential EGFR-TK inhibitor with a binding energy of −9.2 kcal/mol followed by 24-Methylenecholesterol (–9.1 kcal/mol), Campesterol (–9.0 kcal/mol) and Ellagic acid (–9.0 kcal/mol). In comparison, the highest binding affinity from control drugs was displayed by Rociletinib (–9.0 kcal/mol). The molecular dynamics simulation (100 ns) exhibited the structural stability of native EGFR-TK and protein-inhibitor complexes. Further, MM/PBSA computed the binding free energies of protein complex with Delta 7-Avenasterol, 24-Methylenecholesterol, Campesterol and Ellagic acid as −154.559 ± 18.591 kJ/mol, −139.176 ± 19.236 kJ/mol, −136.212 ± 17.598 kJ/mol and −139.513 ± 23.832 kJ/mol, respectively. Non-polar interactions were the major contributors to these energies. The density functional theory analysis also established the stability of these inhibitor compounds. ADMET analysis depicted acceptable outcomes for all top phytochemicals without displaying any toxicity. In conclusion, this report has identified promising EGFR-TK inhibitors to treat several cancers that can be further investigated through laboratory and clinical tests.

Keywords:

• Epidermal growth factor receptor (EGFR)
• molecular docking
• molecular dynamics simulation
• density functional theory
• ADMET

Disclosure statement

No potential conflict of interest was reported by the authors.

Authors contribution

MAY: molecular docking, molecular dynamics simulation, density functional theory and manuscript drafting; SAA: molecular docking and manuscript drafting; SB: MM-PBSA; and SS: MM-PBSA.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.